MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems
Go back to MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.66 -0.09 (2.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.75 | 52 Week High | $2.51 | |||
| Open | $3.75 | 52 Week Low | $0.41 | |||
| Day High | $3.81 | P/E | N/A | |||
| Day Low | $3.64 | EPS | $-0.64 | |||
| Volume | 3,843,656 | |||||
| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.66 -0.09 (2.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.75 | 52 Week High | $2.51 | |||
| Open | $3.75 | 52 Week Low | $0.41 | |||
| Day High | $3.81 | P/E | N/A | |||
| Day Low | $3.64 | EPS | $-0.64 | |||
| Volume | 3,843,656 | |||||

